HCHolly Colognato

Holly Colognato

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Holly Colognato has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Christopher Eyermann

    Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA

    3 shared publications
  • Iva D. Tzvetanova

    Department of Pharmacology, Stony Brook University, Stony Brook, New York 11794

    3 shared publications
  • Jenne Relucio

    Department of Pharmacology, Stony Brook University, Stony Brook, New York, 11794, USA

    3 shared publications
  • Cindy V. Leiton

    Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA

    2 shared publications
  • Jason Galvin

    Department of Pharmacology, Stony Brook University, Stony Brook, New York 11794-8651, USA

    2 shared publications
  • Michael J. Menezes

    Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA

    2 shared publications

Latest Publications

  • Laminin promotes metalloproteinase‐mediated dystroglycan processing to regulate oligodendrocyte progenitor cell proliferation

    by Cindy V. Leiton, Azeez Aranmolate, Christopher Eyermann, Michael J. Menezes, Luisa F. Escobar‐Hoyos, Solomon Husain, Steve J. Winder, Holly Colognato

    The cell surface receptor dystroglycan mediates interactions between oligodendroglia and laminin‐211, an extracellular matrix protein that regulates timely oligodendroglial development. However, dystroglycan's precise role in oligodendroglial development and the potential mechanisms to regulate laminin–dystroglycan interactions remain unknown. Here we report that oligodendroglial dystroglycan is cleaved by metalloproteinases, thereby uncoupling oligodendroglia from laminin binding. Dystroglycan cleavage is selectively stimulated by oligodendrocyte progenitor cell attachment to laminin‐211, but not laminin‐111 or poly‐d‐lysine. In addition, dystroglycan cleavage occurs most prominently in oligodendrocyte progenitor cells, with limited dystroglycan cleavage observed in differentiating oligodendrocytes. When dystroglycan cleavage is blocked by metalloproteinase inhibitors, oligodendrocyte progenitor cell proliferation is substantially decreased. Conversely, expression of the intracellular portion of cleaved dystroglycan results in increased oligodendrocyte progenitor cell proliferation, suggesting that endogenous dystroglycan cleavage may promote oligodendrocyte progenitor cell cycle progression. Intriguingly, while matrix metalloproteinase‐2 and/or ‐9 have been reported to be responsible for dystroglycan cleavage, we find that these two metalloproteinases are neither necessary nor sufficient for cleavage of oligodendroglial dystroglycan. In summary, laminin‐211 stimulates metalloproteinase‐mediated dystroglycan cleavage in oligodendrocyte progenitor cells (but not in differentiated oligodendrocytes), which in turn promotes oligodendrocyte progenitor cell proliferation. This novel regulation of oligodendroglial laminin–dystroglycan interactions may have important consequences for oligodendroglial differentiation, both during development and during disease when metalloproteinase levels become elevated. image A subset of dystroglycan expressed in oligodendrocyte progenitors is cleaved by (1) a metalloproteinase, and, predicted, (2) by a γ‐secretase to generate an intracellular β−dystroglycan fragment. Cleavage occurs preferentially following attachment to the dystroglycan extracellular ligand, laminin‐211. The intracellular portion of cleaved dystroglycan then promotes oligodendrocyte progenitor proliferation, providing a novel reciprocal mechanism by which laminin–dystroglycan interactions influence oligodendroglial development. MMP, matrix metalloproteinase.


  • Laminin regulates postnatal oligodendrocyte production by promoting oligodendrocyte progenitor survival in the subventricular zone

    by Jenne Relucio, Michael J. Menezes, Yuko Miyagoe‐Suzuki, Shin'Ichi Takeda, Holly Colognato

    The laminin family of extracellular matrix proteins are expressed broadly during embryonic brain development, but are enriched at ventricular and pial surfaces where laminins mediate radial glial attachment during corticogenesis. In the adult brain, however, laminin distribution is restricted, yet is found within the vascular basal lamina and associated fractones of the ventricular zone (VZ)‐subventricular zone (SVZ) stem cell niche, where laminins regulate adult neural progenitor cell proliferation. It remains unknown, however, if laminins regulate the wave of oligodendrogenesis that occurs in the neonatal/early postnatal VZ‐SVZ. Here we report that Lama2, the gene that encodes the laminin α2‐subunit, regulates postnatal oligodendrogenesis. At birth, Lama2−/− mice had significantly higher levels of dying oligodendrocyte progenitor cells (OPCs) in the OPC germinal zone of the dorsal SVZ. This translated into fewer OPCs, both in the dorsal SVZ well as in an adjacent developing white matter tract, the corpus callosum. In addition, intermediate progenitor cells that give rise to OPCs in the Lama2−/− VZ‐SVZ were mislocalized and proliferated nearer to the ventricle surface. Later, delays in oligodendrocyte maturation (with accompanying OPC accumulation), were observed in the Lama2−/− corpus callosum, leading to dysmyelination by postnatal day 21. Together these data suggest that prosurvival laminin interactions in the developing postnatal VZ‐SVZ germinal zone regulate the ability, or timing, of oligodendrocyte production to occur appropriately.


  • Dystroglycan promotes filopodial formation and process branching in differentiating oligodendroglia

    by Christopher Eyermann, Kevin Czaplinski, Holly Colognato

    J. Neurochem. (2012) 120, 928–947. During central nervous system (CNS) development, individual oligodendrocytes myelinate multiple axons, thus requiring the outgrowth and extensive branching of oligodendroglial processes. Laminin (Lm)‐deficient mice have a lower percentage of myelinated axons, which may indicate a defect in the ability to properly extend and branch processes. It remains unclear, however, to what extent extracellular matrix (ECM) receptors contribute to oligodendroglial process remodeling itself. In the current study, we report that the ECM receptor dystroglycan is necessary for Lm enhancement of filopodial formation, process outgrowth, and process branching in differentiating oligodendroglia. During early oligodendroglial differentiation, the disruption of dystroglycan–Lm interactions, via blocking antibodies or dystroglycan small interfering RNA (siRNA), resulted in decreased filopodial number and length, decreased process length, and decreased numbers of primary and secondary processes. Later in oligodendrocyte differentiation, dystroglycan‐deficient cells developed fewer branches, thus producing less complex networks of processes as determined by Sholl analysis. In newly differentiating oligodendroglia, dystroglycan was localized in filopodial tips, whereas, in more mature oligodendrocytes, dystroglycan was enriched in focal adhesion kinase (FAK)‐positive focal adhesion structures. These results suggest that dystroglycan–Lm interactions influence oligodendroglial process dynamics and therefore may regulate the myelination capacity of individual oligodendroglia.


  • Glia unglued: How signals from the extracellular matrix regulate the development of myelinating glia

    by Holly Colognato, Iva D. Tzvetanova

    The health and function of the nervous system relies on glial cells that ensheath neuronal axons with a specialized plasma membrane termed myelin. The molecular mechanisms by which glial cells target and enwrap axons with myelin are only beginning to be elucidated, yet several studies have implicated extracellular matrix proteins and their receptors as being important extrinsic regulators. This review provides an overview of the extracellular matrix proteins and their receptors that regulate multiple steps in the cellular development of Schwann cells and oligodendrocytes, the myelinating glia of the PNS and CNS, respectively, as well as in the construction and maintenance of the myelin sheath itself. The first part describes the relevant cellular events that are influenced by particular extracellular matrix proteins and receptors, including laminins, collagens, integrins, and dystroglycan. The second part describes the signaling pathways and effector molecules that have been demonstrated to be downstream of Schwann cell and oligodendroglial extracellular matrix receptors, including FAK, small Rho GTPases, ILK, and the PI3K/Akt pathway, and the roles that have been ascribed to these signaling mediators. Throughout, we emphasize the concept of extracellular matrix proteins as environmental sensors that act to integrate, or match, cellular responses, in particular to those downstream of growth factors, to appropriate matrix attachment. © 2011 Wiley Periodicals, Inc. Develop Neurobiol 71: 924‐955, 2011


  • Dystroglycan modulates the ability of insulin‐like growth factor‐1 to promote oligodendrocyte differentiation

    by Jason Galvin, Christopher Eyermann, Holly Colognato

    The adhesion receptor dystroglycan positively regulates terminal differentiation of oligodendrocytes, but the mechanism by which this occurs remains unclear. Using primary oligodendrocyte cultures, we identified and examined a connection between dystroglycan and the ability of insulin‐like growth factor‐1 (IGF‐1) to promote oligodendrocyte differentiation. Consistent with previous reports, treatment with exogenous IGF‐1 caused an increase in MBP protein that was preceded by activation of PI3K (AKT) and MAPK (ERK) signaling pathways. The extracellular matrix protein laminin was further shown to potentiate the effect of IGF‐1 on oligodendrocyte differentiation. Depletion of the laminin receptor dystroglycan using siRNA, however, blocked the ability of IGF‐1 to promote oligodendrocyte differentiation of cells grown on laminin, suggesting a role for dystroglycan in IGF‐1‐mediated differentiation. Indeed, loss of dystroglycan led to a reduction in the ability of IGF‐1 to activate MAPK, but not PI3K, signaling pathways. Pharmacological inhibition of MAPK signaling also prevented IGF‐1‐induced increases in myelin basic protein (MBP), indicating that MAPK signaling was necessary to drive IGF‐1‐mediated enhancement of oligodendrocyte differentiation. Using immunoprecipitation, we found that dystroglycan, the adaptor protein Grb2, and insulin receptor substrate‐1 (IRS‐1), were associated in a protein complex. Taken together, our results suggest that the positive regulatory effect of laminin on oligodendrocyte differentiation may be attributed, at least in part, to dystroglycan's ability to promote IGF‐1‐induced differentiation.


  • Open Access

    Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development

    by Emory Kuo, Daniel K. Park, Iva D. Tzvetanova, Cindy V. Leiton, Brian S. Cho, Holly Colognato

    J. Neurochem. (2010) 10.1111/j.1471‐4159.2010.06596.x Oligodendrocyte progenitor cells first proliferate to generate sufficient cell numbers and then differentiate into myelin‐producing oligodendrocytes. The signal transduction mediators that underlie these events, however, remain poorly understood. The tyrosine phosphatase Shp1 has been linked to oligodendrocyte differentiation as Shp1‐deficient mice show hypomyelination. The Shp1 homolog, Shp2, has recently been shown to regulate astrogliogenesis, but its role in oligodendrocyte development remains unknown. Here, we report that Shp2 protein levels were developmentally regulated in oligodendrocytes, with Shp2 phosphorylation being promoted by oligodendroglial mitogens but suppressed by laminin, an extracellular matrix protein that promotes oligodendroglial differentiation. In contrast, oligodendrocyte progenitors were found to be unresponsive to mitogens following Shp2, but not Shp1, depletion. In agreement with previous studies, Shp1 depletion led to decreased levels of myelin basic protein in differentiating oligodendrocytes, as well as reduced outgrowth of myelin membrane sheets. Shp2 depletion in contrast did not prevent oligodendrocyte differentiation but promoted expanded myelin membrane outgrowth. Taken together these data suggest that Shp1 and Shp2 have distinct functions in oligodendrocyte development: Shp2 regulates oligodendrocyte progenitor proliferation and Shp1 regulates oligodendrocyte differentiation. Adhesion to laminin may additionally provide extrinsic regulation of Shp2 activity and thus promote the transition from progenitor to differentiating oligodendrocyte.


  • Open Access

    Laminin Alters Fyn Regulatory Mechanisms and Promotes Oligodendrocyte Development

    by Jenne Relucio, Iva D. Tzvetanova, Wei Ao, Sabine Lindquist, Holly Colognato

    Mutations inLAMA2, the gene for the extracellular matrix protein laminin-α2, cause a severe muscular dystrophy termed congenital muscular dystrophy type-1A (MDC1A). MDC1A patients have accompanying CNS neural dysplasias and white matter abnormalities for which the underlying mechanisms remain unknown. Here, we report that in laminin-deficient mice, oligodendrocyte development was delayed such that oligodendrocyte progenitors accumulated inappropriately in adult brains. Conversely, laminin substrates were found to promote the transition of oligodendrocyte progenitors to newly formed oligodendrocytes. Laminin-enhanced differentiation was Src family kinase-dependent and resulted in the activation of the Src family kinase Fyn. In laminin-deficient brains, however, increased Fyn repression was accompanied by elevated levels of the Src family kinase negative regulatory proteins, Csk (C-terminal Src kinase), and its transmembrane adaptor, Cbp (Csk-binding protein). These findings indicate that laminin deficiencies delay oligodendrocyte maturation by causing dysregulation of signaling pathways critical for oligodendrocyte development, and suggest that a normal role for CNS laminin is to promote the development of oligodendrocyte progenitors into myelin-forming oligodendrocytes via modulation of Fyn regulatory molecules.


  • Open Access

    β1 integrins are required for normal CNS myelination and promote AKT-dependent myelin outgrowth

    by Claudia S. Barros, Tom Nguyen, Kathryn S. R. Spencer, Akiko Nishiyama, Holly Colognato, Ulrich Müller

    Oligodendrocytes in the central nervous system (CNS) produce myelin sheaths that insulate axons to ensure fast propagation of action potentials. β1 integrins regulate the myelination of peripheral nerves, but their function during the myelination of axonal tracts in the CNS is unclear. Here we show that genetically modified mice lacking β1 integrins in the CNS present a deficit in myelination but no defects in the development of the oligodendroglial lineage. Instead, in vitro data show that β1 integrins regulate the outgrowth of myelin sheaths. Oligodendrocytes derived from mutant mice are unable to efficiently extend myelin sheets and fail to activate AKT(also known as AKT1), a kinase that is crucial for axonal ensheathment. The inhibition of PTEN, a negative regulator of AKT, or the expression of a constitutively active form of AKT restores myelin outgrowth in culturedβ1-deficient oligodendrocytes. Our data suggest that β1 integrins play an instructive role in CNS myelination by promoting myelin wrapping in a process that depends on AKT.


  • Identification of dystroglycan as a second laminin receptor in oligodendrocytes, with a role in myelination

    by Holly Colognato, Jason Galvin, Zhen Wang, Jenne Relucio, Tom Nguyen, David Harrison, Peter D. Yurchenco, Charles Ffrench-Constant

    Developmental abnormalities of myelination are observed in the brains of laminin-deficient humans and mice. The mechanisms by which these defects occur remain unknown. It has been proposed that, given their central role in mediating extracellular matrix (ECM) interactions, integrin receptors are likely to be involved. However, it is a non-integrin ECM receptor,dystroglycan, that provides the key linkage between the dystrophin-glycoprotein complex (DGC) and laminin in skeletal muscle basal lamina, such that disruption of this bridge results in muscular dystrophy. In addition, the loss of dystroglycan from Schwann cells causes myelin instability and disorganization of the nodes of Ranvier. To date, it is unknown whether dystroglycan plays a role during central nervous system (CNS)myelination. Here, we report that the myelinating glia of the CNS,oligodendrocytes, express and use dystroglycan receptors to regulate myelin formation. In the absence of normal dystroglycan expression, primary oligodendrocytes showed substantial deficits in their ability to differentiate and to produce normal levels of myelin-specific proteins. After blocking the function of dystroglycan receptors, oligodendrocytes failed both to produce complex myelin membrane sheets and to initiate myelinating segments when co-cultured with dorsal root ganglion neurons. By contrast, enhanced oligodendrocyte survival in response to the ECM, in conjunction with growth factors, was dependent on interactions with beta-1 integrins and did not require dystroglycan. Together, these results indicate that laminins are likely to regulate CNS myelination by interacting with both integrin receptors and dystroglycan receptors, and that oligodendrocyte dystroglycan receptors may have a specific role in regulating terminal stages of myelination, such as myelin membrane production, growth, or stability.